Skip to main content
SpringerLink
Log in

Evolution of chronic myelomonocytic leukemia to myeloproliferative neoplasm

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Swerdlow SH, Campo E, Harris NL, Jaffe SS, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haemtopoietic and lymphoid tissues. IARC, Lyon

    Google Scholar 

  2. Bartels S, Schipper E, Hasemeier B, Kreipe H, Lehmann U (2016) Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms. Oncotarget. doi:10.18632/oncotarget.8310

  3. Muramatsu H, Makishima H, Maciejewski JP (2012) Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions. Semin Oncol 39:67–73. doi:10.1053/j.seminoncol.2011.11.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bartels S, Lehmann U, Büsche G, Schlue J, Mozer M, Stadler J, Triviai I, Alchalby H, Kröger N, Kreipe H (2015) SRSF2 and U2AF1 mutations in primary myelofibrosis are associated with JAK2 and MPL but not calreticulin mutation and may independently reoccur after allogeneic stem cell transplantation. Leukemia 29:253–255. doi:10.1038/leu.2014.277

    Article  CAS  PubMed  Google Scholar 

  5. Guglielmelli P, Lasho TL, Rotunno G, Score J, Mannarelli C, Pancrazzi A, Biamonte F, Pardanani A, Zoi K, Reiter A, Duncombe A, Fanelli T, Pietra D, Rumi E, Finke C, Gangat N, Ketterling RP, Knudson RA, Hanson CA, Bosi A, Pereira A, Manfredini R, Cervantes F, Barosi G, Cazzola M, Cross NC, Vannucchi AM, Tefferi A (2014) The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. Leukemia 28:1804–1810. doi:10.1038/leu.2014.76

    Article  CAS  PubMed  Google Scholar 

  6. Lehmann U, Bartels S, Hasemeier B, Geffers R, Schlue J, Büsche G, Hussein K, Kreipe H (2013) SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis. Blood 121:4011–4012. doi:10.1182/blood-2012-11-467662

    Article  CAS  PubMed  Google Scholar 

  7. Boiocchi L, Espinal-Witter R, Geyer JT, Steinhilber J, Bonzheim I, Knowles DM, Fend F, Orazi A (2013) Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease. Mod Pathol 26:204–12. doi:10.1038/modpathol.2012.165

    Article  CAS  PubMed  Google Scholar 

  8. Ortmann CA, Kent DG, Nangalia J, Silber Y, Wedge DC, Grinfeld J, Baxter EJ, Massie CE, Papaemmanuil E, Menon S, Godfrey AL, Dimitripolou D, Guiglielmelli P, Bellosillo B, Besses C, Döhner K, Harrison CN, Vassiliou GS, Vannucchi A, Camphell PJ, Green AR (2015) Effect of mutation order on myeloproliferative neoplasms. N Engl J Med 372:601–612. doi:10.1056/NEJMoa1412098

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lundberg P, Karow A, Nienhold R, Looser R, Hao-Shen H, Nissen I, Girsberger S, Lehmann T, Passweg J, Stern M, Beisel C, Kralovics R, Skoda RC (2014) Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms. Blood 123:2220–2228. doi:10.1182/blood-2013-11-537167

    Article  CAS  PubMed  Google Scholar 

  10. Mason CC, Khorashad JS, Tantravahi SK, Kelley TW, Zabriskie MS, Yan D, Pomicter AD, Reynolds KR, Eiring AM, Kronenberg Z, Sherman RL, Tyner JW, Dalley BK, Dao KH, Yandell M, Drucker BJ, Gotlib J, O’Hare T, Deininger MW (2015) Age-related mutations and chronic myeloid leukemia. Leukemia 30:906–13. doi:10.1038/leu.2015.337

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by a grant of the Deutsche Krebshilfe to HK and GB (grant number 1097154, TP A,D).

Author information

Authors and Affiliations

  1. Institute of Pathology, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, 30625, Hannover, Germany

    S. Bartels, U. Lehmann, G. Büsche, J. Schlue & H. Kreipe

Authors
  1. S. Bartels
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Büsche
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Schlue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Kreipe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Kreipe.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bartels, S., Lehmann, U., Büsche, G. et al. Evolution of chronic myelomonocytic leukemia to myeloproliferative neoplasm. Ann Hematol 95, 1377–1380 (2016). https://doi.org/10.1007/s00277-016-2699-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2699-6

Keywords

Search

Navigation